Following an application from Potters Ltd, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Mumomega® on central nervous system development (Question No EFSA-Q-2008-328) [The EFSA Journal (2008) 902, pp. 1-9.]. The claim proposed by the applicant was worded as follows: ‘Mumomega® provides the nourishments that support healthy central nervous system development’.
Recital 23, Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refu…
In forcesince 29 Oct 2009